HCA Holdings price target raised to $72 from $68 at Deutsche Bank Deutsche Bank said that HCA, which had pre-announced higher than expected Q2 results and previously raised its FY14 guidance, provided additional details on the consistent volume trends across its divisions in its full report. The firm said HCA's cash flow remains impressive and raised its price target on the stock to $72 from $68.
HCA Holdings sees Q2 EPS about $1.18, consensus $1.32 Sees Q2 revenue $9.9B, consensus $9.77B. Q2 adjusted EBITDA is expected to be approximately $2.008B, compared to $2.0B in the previous year’s second quarter. Same facility admissions for Q2 increased 4.1%, while same facility equivalent admissions increased 4.9%. Same facility emergency room visits for Q2 increased 7.4% from the prior year’s second quarter. Same facility revenue per equivalent admission is expected to increase approximately 2.8% in Q2 compared to the prior year’s second quarter, after adjusting second quarter 2014 revenues to exclude the impact of the $142M adjustment to increase revenues related to the Texas Medicaid Waiver Program.